The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of cabozantinib in metastatic castrate resistant prostate cancer (mCRPC) with visceral metastases (VM) with very small nuclear circulating tumor cell (vsnCTC) association studies.
 
Edwin M. Posadas
Honoraria - Pfizer
Expert Testimony - Breckenridge Pharmaceuticals
Travel, Accommodations, Expenses - TRACON Pharma
 
Kevin Scher
No Relationships to Disclose
 
Jie-Fu Chen
No Relationships to Disclose
 
Margarit Sievert
No Relationships to Disclose
 
Amy Oppenheim
No Relationships to Disclose
 
Nancy P. Moldawer
No Relationships to Disclose
 
Beatrice Knudsen
No Relationships to Disclose
 
Michael Freeman
No Relationships to Disclose
 
Neil Bhowmick
No Relationships to Disclose
 
Andre Rogatko
No Relationships to Disclose
 
Hsian-Rong Tseng
No Relationships to Disclose
 
Leland WK Chung
No Relationships to Disclose
 
Robert A. Figlin
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Exelixis (Inst); Immatics (Inst); Peloton Therapeutics (Inst)